Comparing Standard and Modified Bobath Physiotherapy in Children With Spastic Cerebral Palsy

Evaluating the Efficacy of the Modified Bobath Approach in Children with Spastic Cerebral Palsy at Livingstone University Teaching Hospital: A Crossover Study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202512685522786

Enrollment

Registered

2025-12-17

Start date

2024-08-01

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nervous System Diseases

Interventions

Modified Bobbath Approach

Standard Bobbath Therapy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Children diagnosed with spastic cerebral palsy by a qualified clinician. • Age range 3 months to 4 years • Classified within Gross Motor Function Classification System (GMFCS) Levels I–III. • Medically stable and able to participate in physiotherapy sessions. • Able to attend all scheduled treatment sessions and assessments throughout the study period. • Parent or guardian able to provide informed consent.

Exclusion criteria

Exclusion criteria: Children with mixed, dyskinetic, or ataxic types of cerebral palsy. • Presence of severe cognitive impairment that prevents participation in structured physiotherapy. • Orthopedic or neurological surgery within the past 6 months. • Botulinum toxin injections within the past 3 months. • Uncontrolled seizures or other medical conditions that contraindicate active therapy. • Severe musculoskeletal deformities that limit safe handling or participation. • Inability of the parent or guardian to commit to the full 24-week study schedule.

Design outcomes

Primary

Measure	Time frame
Reduction in spasticity levels in children with spastic cerebral palsy, measured using the Modified Ashworth Scale (MAS) at baseline and at the end of each 12-week treatment phase.	—

Secondary

Measure	Time frame
Changes in gross motor function, assessed using the Gross Motor Function Measure (GMFM) at baseline and at the end of each 12-week treatment phase. • Improvements in mobility and activities of daily living, evaluated through therapist-guided functional assessments at each measurement point. • Goal attainment outcomes, measured using individualized goal-setting tools (such as GAS) at baseline and at the end of each 12-week phase.	—

Measure

Time frame

Changes in gross motor function, assessed using the Gross Motor Function Measure (GMFM) at baseline and at the end of each 12-week treatment phase. • Improvements in mobility and activities of daily living, evaluated through therapist-guided functional assessments at each measurement point. • Goal attainment outcomes, measured using individualized goal-setting tools (such as GAS) at baseline and at the end of each 12-week phase.

—

Countries

Zambia

Contacts

Public ContactGeofrey Moyo

Co Supervisor

geofreymoyo@gmail.com+260977881866

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026